Log in
Enquire now
Arkuda Therapeutics

Arkuda Therapeutics

Arkuda Therapeutics is a small Molecule for Dementia.

OverviewStructured DataIssuesContributors

Contents

arkudatx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Email Address
info@arkudatx.com
Investors
Tekla Capital Management
Tekla Capital Management
BioInnovation Capital
BioInnovation Capital
Pfizer Venture Investments
Pfizer Venture Investments
Eli Lilly
Eli Lilly
Surveyor Capital
Surveyor Capital
Cormorant Asset Management
Cormorant Asset Management
Pivotal bioVenture Partners
Pivotal bioVenture Partners
Mission BioCapital
Mission BioCapital
...
Total Funding Amount (USD)
108,000,000
Latest Funding Round Date
February 15, 2022
Latest Funding Type
Series B
Series B
Country
United States
United States

Other attributes

Latest Funding Round Amount (USD)
64,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Arkuda Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.